10 completed, 4 terminated, 2 withdrawn, 1 suspended. 7 Not applicable, 3 Phase 1, 3 Phase 4, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 7 | Terminated 3, Completed 2, Withdrawn 2 |
| Phase 1 | 3 | Completed 3 |
| Phase 4 | 3 | Completed 1, Suspended 1, Terminated 1 |
| Phase 2 | 1 | Completed 1 |
Follow B. Braun Medical Inc.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Resveratrol Excipient Paclitaxel Coated Balloon for Coronary Treatment SeQuent Please ReX, Plain old balloon angioplasty (POBA) - In-stent Coronary Artery Restenosis, Coronary Artery Restenosis | Not applicable | Withdrawn | B. Braun Medical Inc. | 2023-02-10 | 2023-02-14 | |
| Pharmacokinetics and Safety of Cefazolin 3gm DUPLEX in Adults Cefazolin 3gm for Injection USP and Dextrose Injection USP - Infections | Phase 1 | Completed | B. Braun Medical Inc. | 12 | 2022-04-05 | 2025-02-28 |
| Effect of B. Braun Peripheral Advantage Program on Complications, Indwell Time and First Stick Success of PIVC Therapy B. Braun Peripheral Advantage (PA) Program, Hospital Standard of Care - Complications Associated With Device | Not applicable | Terminated | B. Braun Medical Inc. | 44 | 2020-01-24 | 2022-08-01 |
| Comparison of Clorotekal and Bupivacaine for Short Obstetric Surgery Chloroprocaine Injection [Clorotekal], Bupivacaine Hydrochloride 0.75% Injection Solution - Anesthesia, Spinal | Phase 4 | Suspended | Oregon Health and Science University | 27 | 2019-10-24 | 2024-06-21 |
| Prontosan Quality of Life Study in Patients With Chronic Leg Wound(s) Prontosan Wound Irrigation Solution and Prontosan Wound Gel - Wound of Lower Leg (Physical Finding) | Not applicable | Terminated | B. Braun Medical Inc. | 43 | 2018-02-20 | 2020-12-08 |
| Safety of 1 g and 2 g of Cefazolin in Pediatric Subjects Cefazolin 1 g Infusion, Cefazolin 2 g Infusion - Postoperative Infection | Phase 4 | Terminated | B. Braun Medical Inc. | 61 | 2017-11-20 | 2020-07-13 |
| OR PathTrac (Tracking Intra-operative Bacterial Transmission) Bacterial Infections | Completed | Sundara Reddy | 83 | 2017-09-05 | 2019-03-01 | |
| Blood Levels of Local Anaesthetic in Knee Arthroplasty Using a Continuous Infusion Device Ropivacaine - Osteoarthritis, Knee | Unknown | Golden Jubilee National Hospital | 30 | 2013-09-01 | 2013-09-05 | |
| Pediatric Cefazolin PK Study Cefazolin 1 GM Injection, Cefazolin 2 GM Injection - Infections | Phase 1 | Completed | B. Braun Medical Inc. | 12 | 2013-03-01 | 2017-07-21 |
| Blood Pressure Guided Biofeedback on Hemodialysis and the Reduction of IntraDialytic Hypotension BioLogic RR, Hemodialysis without biofeedback - Hypotension | Not applicable | Completed | University of Calgary | 25 | 2013-01-01 | 2014-06-17 |
| Blood Levels of Local Anaesthetic in Hip Arthroplasty Ropivacaine - Osteoarthritis, Hip | Completed | Golden Jubilee National Hospital | 20 | 2012-08-01 | 2013-06-05 | |
| Blood Levels of Local Anaesthetic in Knee Arthroplasty Ropivacaine - Arthritis of Knee | Completed | Golden Jubilee National Hospital | 20 | 2012-08-01 | 2013-06-11 | |
| Prontosan Versus Saline in the Cleansing of Chronic Leg Ulcers in Diabetic Patients Prontosan, Saline - Diabetic Complications | Not applicable | Withdrawn | B. Braun Medical Inc. | 2012-03-01 | 2013-07-16 | |
| S.A.F.E.BT System Extracorporeal Treatment With DIAPACT CRRT S.A.F.E.BT - Severe Sepsis | Not applicable | Terminated | B. Braun Medical Inc. | 16 | 2011-04-01 | 2018-10-12 |
| Pharmacokinetics and Safety of Cefazolin 2g in DUPLEX Cefazolin 2g for Injection USP and Dextrose Injection USP, Cefazolin 1.5g - Infection | Phase 1 | Completed | B. Braun Medical Inc. | 24 | 2009-12-01 | 2013-07-16 |
| A Study of the Effect of Gemcitabine With Fish Oil in Patients With Advanced Pancreatic Cancer Lipidem fish oil infusion + Gemcitabine chemotherapy - Pancreatic Neoplasms | Phase 2 | Completed | University Hospitals, Leicester | 50 | 2009-10-01 | 2014-12-04 |
| (H.E.L.P.)Apheresis Therapy to Compare the Reduction of LDL (Low Density Lipoprotein) Cholesterol Secura then Futura, Futura then Secura - Hypercholesterolemia | Not applicable | Completed | B. Braun Medical Inc. | 18 | 2007-08-01 | 2018-09-14 |
| Low-Density Lipoprotein (LDL) Apheresis Using H.E.L.P. Therapy HELP Secura (apheresis treatment) - Familial Hypercholesterolemia | Phase 4 | Completed | B. Braun Medical Inc. | 113 | 1999-12-01 | 2024-04-02 |
Infections (3) · Hypercholesterolemia (2) · Bacterial Infections (1) · Carcinoma (1) · Coronary Restenosis (1) · Diabetes Complications (1) · Hyperlipoproteinemia Type II (1) · Hypotension (1) · Neoplasms (1) · Osteoarthritis, Hip (1) · Osteoarthritis, Knee (1) · Pancreatic Neoplasms (1) · Sepsis (1)
Ropivacaine (3) · Cefazolin (2) · Biofeedback, Psychology (1) · Bupivacaine (1) · Gemcitabine (1) · Renal Dialysis (1) · chloroprocaine (1)
United States (11) · United Kingdom (4) · Canada (1)
Michael Gill, MBChB (3) · Ashley Dennison, MD FRCS (1) · Azra Hussaini, MD (1) · Brandon M Togioka, MD (1) · Camilla M Jaekel, RN (1) · Gerit Mulder, DPM (1) · Jennifer M MacRae, MD (1) · Jorge Saucedo, MD, MBA (1) · Matthew Metcalfe, MA MD FRCS (1) · Michael L Schmitz, MD (1) · Patrick Moriarty, M.D. (1) · Paul Thompson, M.D. (1) · Robert Wilkins, MBChB FRCA (1) · Sundara Reddy, MBBS, FRCA (1) · William Ennis, DO (1)